Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria.
Mefloquine has an established place in the treatment of chloroquine-resistant falciparum malaria. To investigate mefloquine pharmacokinetics in pregnancy, 9 untreated pregnant women aged 16-33 years and 8 non-pregnant females aged 16-38 years received an average of 15 (range 13-19) mg mefloquine/kg...
Main Authors: | Na Bangchang, K, Davis, T, Looareesuwan, S, White, N, Bunnag, D, Karbwang, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
1994
|
Títulos similares
-
Absorption kinetics of mefloquine in pregnant patients with chloroquine-resistant falciparum malaria
por: Na Bangchang, K, et al.
Publicado: (1990) -
Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria.
por: Nosten, F, et al.
Publicado: (1991) -
MEFLOQUINE PHARMACOKINETICS AND RESISTANCE IN CHILDREN WITH ACUTE FALCIPARUM-MALARIA
por: Nosten, E, et al.
Publicado: (1991) -
Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study.
por: Nosten, F, et al.
Publicado: (1990) -
Population pharmacokinetics of mefloquine in patients with acute falciparum malaria.
por: Simpson, J, et al.
Publicado: (1999)